Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 6

Effects of lithium use on renal structure in smoking patients with bipolar disorder: a computed tomography-based volumetric study

Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings suggest that the unadjusted eGFR difference is not robust to adjustment for baseline demographic and clinical characteristics, while a confounder-adjusted difference in normalized renal volume between the lithium group and controls represents a novel finding that warrants confirmation in prospective studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To evaluate the association between lithium and renal structure using computed tomography (CT)-based volumetric methods in smoking patients with bipolar disorder, and its relationship with renal function indicators.
📊
Key Findings & Data:Methods: This retrospective, cross-sectional, single-center study included 165 participants with contrast-enhanced abdominal CT: smoking patients with bipolar disorder receiving lithium (n=55), lithium-naïve smoking patients with bipolar disorder (n=55), and smoking controls without known psychiatric or renal disease (n=55).
💡
Conclusion & Impact:These findings suggest that the unadjusted eGFR difference is not robust to adjustment for baseline demographic and clinical characteristics, while a confounder-adjusted difference in normalized renal volume between the lithium group and controls represents a novel finding that warrants confirmation in prospective studies.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Tomography · X-ray computed · glomerular filtration rate

Abstract

Aims: To evaluate the association between lithium and renal structure using computed tomography (CT)-based volumetric methods in smoking patients with bipolar disorder, and its relationship with renal function indicators. Methods: This retrospective, cross-sectional, single-center study included 165 participants with contrast-enhanced abdominal CT: smoking patients with bipolar disorder receiving lithium (n=55), lithium-naïve smoking patients with bipolar disorder (n=55), and smoking controls without known psychiatric or renal disease (n=55). Renal parenchymal volume, dimensions, cortical thickness at four sites, and cystic changes were assessed by two radiologists using 3D Slicer software; volumes were normalized to body surface area (BSA). Serum creatinine, estimated glomerular filtration rate (eGFR), and other biochemical parameters were recorded. Results: Interobserver agreement was high (ICC=0.81). In unadjusted analysis, eGFR differed among groups (p=0.037) and was lower in the lithium group than in controls (difference between group medians, 8.8 ml/min/1.73 m²; p=0.011), but this difference was no longer significant after adjustment for age, gender, body-mass index (BMI), and pack-years (p=0.503); creatinine did not differ (p=0.586). In unadjusted comparisons, renal parenchymal volume, dimensions, and BSA-normalized volume did not differ among groups (all p>0.09). Right lower-pole cortical thickness showed an isolated unadjusted difference between the lithium and non-lithium groups (p=0.016) that did not survive correction for the four regional comparisons. Renal cyst frequency was similar among groups (p=0.572). Total renal volume correlated positively with height, weight, and BMI. In these adjusted models, BSA-normalized renal volume was significantly lower in the lithium group than in controls (B=-22.8 cm³/m², 95% CI -41.0 to -4.7; p=0.014), a difference not apparent in the unadjusted comparison. Conclusion: Although unadjusted eGFR was lower in lithium-treated patients with bipolar disorder than in controls, this difference did not persist after covariate adjustment for age, gender, BMI, and smoking exposure. Renal parenchymal volume, dimensions, and cyst frequency did not differ significantly on unadjusted comparison, although BSA-normalized renal volume was significantly lower in the lithium group after covariate adjustment. These findings suggest that the unadjusted eGFR difference is not robust to adjustment for baseline demographic and clinical characteristics, while a confounder-adjusted difference in normalized renal volume between the lithium group and controls represents a novel finding that warrants confirmation in prospective studies.

🔖

Cite This Article

Tonkaz, M., Kaya, A., Şimşek, M. H., Önal, Ö., Naycı, N. A., Tonkaz, G. Y., Erkal, D., Tonkaz, G. (2026). Effects of lithium use on renal structure in smoking patients with bipolar disorder: a computed tomography-based volumetric study. Anatolian Current Medical Journal, Volume: 8 Issue: 6. https://ajindex.com/articles/1667873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Malhi GS, Gessler D, Outhred T. The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. J Affect Disord. 2017;217:266-280. doi:10.1016/j.jad.2017.03.052
  2. Ercis M, Gonzalez Suarez ML, Singh B. Lithium and kidney disease. Mayo Clin Proc. 2025;100(1):19-25. doi:10.1016/j.mayocp.2024.10.008
  3. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721-728. doi:10.1016/S0140-6736(11)61516-X
  4. Rodrigo C, de Silva NL, Gunaratne R, Rajapakse S, De Silva VA, Hanwella R. Lower estimated glomerular filtration rates in patients on long term lithium: a comparative study and a meta-analysis of literature. BMC Psychiatry. 2014;14(1):4. doi:10.1186/1471-244X-14-4
  5. Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386(9992):461-468. doi:10.1016/S0140-6736(14)61842-0
  6. Bocchetta A, Ardau R, Fanni T, et al. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med. 2015;13:12. doi:10.1186/s12916-014-0249-4
  7. Macaron MM, Abou Rjeily M, Macaron R, et al. Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders. Ther Adv Psychopharmacol. 2026;16:20451253261419633. doi:10.1177/20451253261419633
  8. Schoretsanitis G, de Filippis R, Brady BM, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: a systematic review and meta-analysis. Bipolar Disord. 2022;24(3):264-274. doi:10.1111/bdi.13154
  9. Gislason G, Indridason OS, Sigurdsson E, Palsson R. Risk of chronic kidney disease in individuals on lithium therapy in Iceland: a nationwide retrospective cohort study. Lancet Psychiatry. 2024;11(12):1002-1011. doi:10.1016/S2215-0366(24)00324-9
  10. Van Alphen AM, Bosch TM, Kupka RW, Hoekstra R. Chronic kidney disease in lithium-treated patients, incidence and rate of decline. Int J Bipolar Disord. 2021;9(1):1. doi:10.1186/s40345-020-00204-2
  11. Hayes JF, Osborn DPJ, Francis E, et al. Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder. BMC Med. 2021;19(1):99. doi:10.1186/s12916-021-01964-z
  12. Farres MT, Ronco P, Saadoun D, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology. 2003;229(2):570-574. doi:10.1148/radiol.2292020758
  13. Tuazon J, Casalino D, Syed E, Batlle D. Lithium-associated kidney microcysts. ScientificWorldJournal. 2008;8:828-829. doi:10.1100/tsw.2008.112
  14. Karaosmanoğlu AD, Butros SR, Arellano R. Imaging findings of renal toxicity in patients on chronic lithium therapy. Diagn Interv Radiol. 2013;19(4):299-303. doi:10.5152/dir.2013.097
  15. Eid HA, Moazen EM, Elhussini M, et al. The influence of smoking on renal functions among apparently healthy smokers. J Multidiscip Healthc. 2022;15:2969-2978. doi:10.2147/JMDH.S392848
  16. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612. doi:10.7326/0003-4819-150-9-200905050-00006
  17. Bosi A, Clase CM, Ceriani L, et al. Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden. JAMA Netw Open. 2023;6(7):e2322056. doi:10.1001/jamanetworkopen.2023.22056
  18. Fransson F, Werneke U, Harju V, et al. Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts. Lancet Psychiatry. 2022;9(10):804-814. doi:10.1016/S2215-0366(22)00265-6
  19. Golic M, Aiff H, Attman PO, et al. Lifetime risk of severe kidney disease in lithium-treated patients: a retrospective study. Int J Bipolar Disord. 2023;11(1):39. doi:10.1186/s40345-023-00319-2
  20. Beunon P, Barat M, Dohan A, et al. MRI-based kidney radiomic analysis during chronic lithium treatment. Eur J Clin Invest. 2022;52(5):e13756. doi:10.1111/eci.13756